Logo image
Alagille Syndrome
Journal article   Peer reviewed

Alagille Syndrome

Ellen Mitchell, Melissa Gilbert and Kathleen M Loomes
Clinics in liver disease, v 22(4), pp 625-641
01 Nov 2018
PMID: 30266153

Abstract

Alagille Syndrome - complications Alagille Syndrome - diagnosis Alagille Syndrome - genetics Alagille Syndrome - therapy Genetic Testing Humans Jagged-1 Protein - genetics Liver Transplantation Receptor, Notch2 - genetics Signal Transduction
Alagille syndrome is a complex multisystem autosomal dominant disorder with a wide variability in penetrance of clinical features. A majority of patients have pathogenic mutations in either the JAG1 gene, encoding a Notch pathway ligand, or the receptor NOTCH2. No genotype-phenotype correlations have been found in any organ system. Liver disease is a major cause of morbidity in this population, whereas cardiac and vascular involvement accounts for most of the mortality. Current therapies are supportive, but the future is promising for the development of targeted interventions to augment Notch pathway signaling in involved tissues.

Metrics

26 Record Views
133 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Gastroenterology & Hepatology
Logo image